Login / Signup
Non-Aspergillus invasive mould infections in patients treated with ibrutinib.
Amalia Anastasopoulou
Adam J DiPippo
Dimitrios P Kontoyiannis
Published in:
Mycoses (2020)
Although rare, NAIMIs should be considered in patients who receive IBR.
Keyphrases
</>
chronic lymphocytic leukemia